Advertisement

Coordinating Outpatient Care for Pregnant and Postpartum Women with Opioid Use Disorder: Implications from the COACHH Program

  • Fran E. Hodgins
  • Jessica M. LangEmail author
  • Gabriel G. Malseptic
  • Lauren H. Melby
  • Kathleen A. Connolly
From the Field
  • 21 Downloads

Abstract

Purpose With the rise of opioid use disorder (OUD) among women of childbearing age, effective care models must address the complex needs of pregnant and postpartum women with OUD. This paper describes promising practices and implementation challenges from the Collaborative Outreach and Adaptable Care at Hallmark Health (COACHH) program, which utilizes a collaborative care team to coordinate outpatient care for pregnant and postpartum women with OUD. Description Semi-structured interviews were conducted with members of the COACHH team to discuss program logistics and takeaways. Interviews were coded to analyze themes. Assessment The COACHH team identified the need for specialized, time-intensive care coordination to address the unique needs of pregnant and postpartum women with OUD. First, the team prioritizes forming trusting relationships with patients to holistically understand patients’ needs, improve patient engagement, and connect patients with resources. Second, the wide range of patient needs necessitates a team with diverse professional skills, whose members share an understanding of addiction and pregnancy. Third, finding the right quantitative outcome measurements is difficult; instead, success is measured in qualitative terms, stressing relationships and engagement as signals of change. Finally, the team encounters challenges with low referral rates, lack of provider awareness, and fragmented services. Conclusion We identified care delivery and program design considerations that may inform others who wish to coordinate care for pregnant and postpartum women with OUD. The program continues to face challenges enrolling patients and measuring outcomes, reflecting the need for tailored approaches and metrics for this population.

Keywords

Pregnancy Substance use disorder Opioid use disorder Community health worker Patient-centered care 

Notes

Acknowledgements

The authors wish to gratefully acknowledge the following individuals for their thoughtful review and feedback in preparation of this case report: Carol Plotkin, Hallmark Health System and the offices of the Executive Director and General Counsel, Massachusetts Health Policy Commission. This study was funded by the Massachusetts Health Policy Commission.

Compliance with Ethical Standards

This paper is not based upon clinical study or patient data.

References

  1. ACOG Committee on Health Care for Underserved Women and American Society of Addiction Medicine. (2012). ACOG committee opinion no. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstetrics and Gynecology, 119(5), 1070–1076.CrossRefGoogle Scholar
  2. Daley, M., Argeriou, M., & McCarty, D. (1998). Substance abuse treatment for pregnant women: A window of opportunity? Addictive Behaviors, 23(2), 239–249.CrossRefGoogle Scholar
  3. Diop, H. (2018). Maternal mortality and morbidity review in massachusetts: Substance use among pregnancy-associated deaths—Massachusetts, 2005–2014. Retreived September 27, 2018 from https://www.mass.gov/files/documents/2018/05/02/ma-maternal-mortality-and-substance-use-april-2018.pdf.
  4. Huhn, A. S., & Dunn, K. E. (2017). Why aren’t physicians prescribing more buprenorphine? Journal of Substance Abuse Treatment, 78, 1–7.CrossRefGoogle Scholar
  5. Jones, H. E., Deppen, K., Hudak, M. L., Leffert, L., McClelland, C., Sahin, L., … Creanga, A. A. (2014). Clinical care for opioid-using pregnant and postpartum women: The role of obstetric providers. American Journal of Obstetrics and Gynecology, 210(4), 302–310.CrossRefGoogle Scholar
  6. Krans, E. E., Cochran, G., & Bogen, D. L. (2015). Caring for opioid-dependent pregnant women: Prenatal and postpartum care considerations. Clinical Obstetrics and Gynecology, 58(2), 370–379.CrossRefGoogle Scholar
  7. Krans, E. E., & Patrick, S. W. (2016). Opioid use disorder in pregnancy: Health policy and practice in the midst of an epidemic. Obstetrics & Gynecology, 128(1), 4–10.CrossRefGoogle Scholar
  8. Malseptic, G. G., Melby, L. H., & Connolly, K. A. (2017). Complex care models to achieve accountable care readiness: Lessons from two community hospitals. Healthcare, 6(1), 74–78.CrossRefGoogle Scholar
  9. Marcellus, L., MacKinnon, K., Benoit, C., Phillips, R., & Stengel, C. (2015). Reenvisioning success for programs supporting pregnant women with problematic substance use. Qualitative Health Research, 25(4), 500–512.CrossRefGoogle Scholar
  10. Massachusetts Department of Public Health. (2017). Massachusetts state health assessment. Retrieved September 25, 2018 from https://www.mass.gov/service-details/2017-state-health-assessment.
  11. Massachusetts Health Policy Commission. (2016). CHART phase 2 awards: Hallmark health system. Retrieved September 25, 2018 from http://www.mass.gov/anf/budget-taxes-and-procurement/oversight-agencies/health-policy-commission/investment-programs/chart/phase-2/hallmark-health-system.pdf.
  12. Metz, V., Köchl, B., & Fischer, G. (2012). Should pregnant women with substance use disorders be managed differently? Neuropsychiatry, 2(1), 29–41.CrossRefGoogle Scholar
  13. Milligan, K., Niccols, A., Sword, W., Thabane, L., Henderson, J., Smith, A., & Liu, J. (2010). Maternal substance use and integrated treatment programs for women with substance abuse issues and their children: A meta-analysis. Substance Abuse Treatment, Prevention, and Policy, 5, 21.CrossRefGoogle Scholar
  14. Morton, J., & Konrad, S. C. (2009). Introducing a caring/relational framework for building relationships with addicted mothers. Journal of Obstetric, Gynecologic, and Neonatal Nursing: JOGNN, 38(2), 206–213.CrossRefGoogle Scholar
  15. Racine, N., Motz, M., Leslie, M., & Pepler, D. (2009). Breaking the cycle pregnancy outreach program: Reaching out to improve the health and well-being of pregnant substance involved mothers. Journal of the Association for Research on Mothering, 11, 279–290.Google Scholar
  16. Roberts, S. C. M., & Pies, C. (2011). Complex calculations: How drug use during pregnancy becomes a barrier to prenatal care. Maternal and Child Health Journal, 15(3), 333–341.CrossRefGoogle Scholar
  17. Saia, K. A., Schiff, D., Wachman, E. M., Mehta, P., Vilkins, A., Sia, M., Price, J., … Bagley, S. (2016). Caring for pregnant women with opioid use disorder in the USA: Expanding and improving treatment. Current Obstetrics and Gynecology Reports, 5(3), 257–263.CrossRefGoogle Scholar
  18. Schiff, D. M., Nielsen, T., Terplan, M., Hood, M., Bernson, D., Diop, H.,.. . Land, T. (2018). Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstetrics & Gynecology, 132(2), 466–474.CrossRefGoogle Scholar
  19. Stone, R. (2015). Pregnant women and substance use: Fear, stigma, and barriers to care. Health & Justice, 3, 2.CrossRefGoogle Scholar
  20. Sutter, M. B., Gopman, S., & Leeman, L. (2017). Patient-centered care to address barriers for pregnant women with opioid dependence. Obstetrics and Gynecology Clinics of North America, 44(1), 95–107.CrossRefGoogle Scholar
  21. Sweeney, P. J., Schwartz, R. M., Mattis, N. G., & Vohr, B. (2000). The effect of integrating substance abuse treatment with prenatal care on birth outcome. Journal of Perinatology, 20(4), 219–224.CrossRefGoogle Scholar
  22. Terplan, M., McNamara, E. J., & Chisolm, M. S. (2012). Pregnant and non-pregnant women with substance use disorders: The gap between treatment need and receipt. Journal of Addictive Diseases, 31(4), 342–349.CrossRefGoogle Scholar
  23. Wolfe, E. L., Guydish, J. R., Santos, A., Delucchi, K. L., & Gleghorn, A. (2007). Drug treatment utilization before, during and after pregnancy. Journal of Substance Use, 12(1), 27–38.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Fran E. Hodgins
    • 1
  • Jessica M. Lang
    • 1
  • Gabriel G. Malseptic
    • 1
  • Lauren H. Melby
    • 1
  • Kathleen A. Connolly
    • 1
  1. 1.Massachusetts Health Policy CommissionBostonUSA

Personalised recommendations